(PharmaNewsWire.Com, April 12, 2022 ) The Regenerative Therapies Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like “Online Bachelor’s Degree in General Studies with a Concentration in Healthcare” is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to professionals bringing conventional skills in communication, care, and leadership with new-fangled skills in analytics and technology. So, “being value-based” would hold value in the healthcare vertical in the future.
According to the latest market report, the global regenerative therapies market is expected to expand at a CAGR of 8.7% over the forecast period 2021 – 2031.
The market is segmented based on tissue type, application type, end user type, and region. On the basis of tissue type, the overall market has been segmented into allografts, xenografts, and alloplasts.
On the basis of application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopedic, CNS disease treatment, and others, which include diabetes, autonomous diseases, ocular, and oncology.
On the basis of end-user, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes. By tissue type, the allografts segment is expected to remain the largest segment.
Acelity L.P. Inc.
Nuo Therapeutics, Inc. (Cytomedix).
Astellas Pharma US, Inc.
Organovo Holdings Inc.
Shire Pharmaceuticals Limited.
Cytori Therapeutics Inc.
The long-term effectiveness of the treatment and higher its higher biocompatibility with the patient is expected to contribute to the rise in its popularity over the forecast period. The allografts tissue type segment is expected to reach a substantial market value of by the end of the forecast period.
Allografts tissue is also expected to emerge as the most preferred tissue type for both patients and physicians, globally, over the forecast period. The second most popular tissue type choice is xenografts, which are basically prepared by using various animal tissues.
On the basis of the application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopedic, CNS disease treatment, and others (which includes diabetes, autonomous diseases, ocular, and oncology). Currently, a majority of the patients and surgeons globally prefer regenerative therapies for orthopedic, soft tissue repair, and cardiovascular problems.
On the basis of the end user segment type, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes. Currently, hospitals are the most preferred option for patients globally.
On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific & Japan, and the MEA regions.
Rising per capita healthcare expenditure and contribution to GDP, increasing funding & government support for the development of regenerative therapies, as well as surge in incidences of chronic diseases are major factors driving the growth of the global regenerative therapies market currently.
Other trends driving the market growth include industry maturation, advancements in technology, and increasing demand for long-term results and shorter-time therapeutic procedures by patients. However, the market is expected to observe regulatory re-establishment with an increase in regenerative procedures and standardization of therapies over the forecast period.
The absence of standard regulations and legislations is leading to the invasion of many local players in both the developed and emerging regions. Moreover, high gestation period and time-to-market due to lengthy clinical trials, a large number of product recall within a short span post-approval, and lack of financial-backing by smaller firms are among the major factors hampering the growth of regenerative therapies market currently.
This report assesses trends driving each market segment and offers analysis and insights about the potential of regenerative therapies in specific regions. North America market is estimated to dominate the overall regenerative therapies market, accounting for a maximum value share of the global market by the end of 2021.
By 2031, North America and Europe markets are expected to account for over three-fourth revenue share of the global regenerative therapies market. In terms of value, North America is estimated to be the dominant market accounting for 55% global market share in 2021.
Pneumatic Compression Therapy Market - Global pneumatic compression sleeve segment is projected to be the most attractive segment with a market value of more than US$ 200 Mn in 2017 and set for valuation of US$ 670 Mn by 2025 end.
Medical Implants Sterile Packaging Market - Global medical implants sterile packaging market is estimated to increase at an impressive CAGR of 6.5% in terms of value throughout the forecast period 2016 – 2024.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: